42 results
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
as Chair of the Audit Committee and a member of the Compensation Committee and Corporate Governance/Nominations Committee.
SIGNATURE
Pursuant
8-K
HEPA
Hepion Pharmaceuticals Inc
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
Committee and a member of the Corporate Governance/Nominations Committee.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
DEFA14A
t4cv3oo6xcs nc3he
26 Jul 22
Additional proxy soliciting materials
4:05pm
DEFA14A
4s2 66wzsuq
29 Jun 22
Additional proxy soliciting materials
5:49pm
DEFA14A
fnepwee3vndmvxdf
14 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
ybxtf9
9 Jun 21
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
9:06am
8-K
d1eocbu1070
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm